Top Markets
Coin of the day
Synairgen plc Synairgen plc

Synairgen plc

SNG
Rang in aandelen #40400
Synairgen plc specializes in the research and development of pharmaceutical... Synairgen plc specializes in the research and development of pharmaceutical treatments for various respiratory conditions. Its product pipeline includes SNG001, an inhaled interferon beta currently being developed for COVID-19. The company is also advancing an inhaled form of interferon beta (IFN-ß) through Phase II clinical trials for the management of asthma triggered by common colds and influenza, as well as for the treatment or prevention of chronic obstructive pulmonary disease. Furthermore, Synairgen is developing a LOXL2 inhibitor intended for treating idiopathic pulmonary fibrosis (IPF). To support the development of this LOXL2 inhibitor, the company maintains a licensing and collaboration agreement with Pharmaxis Ltd. Synairgen plc was established in 2004 and is headquartered in Southampton, United Kingdom.
Aandeelprijs
$0.01292666
Laatst gesynchroniseerd: 2025-04-08
Marktkapitalisatie
$157.54K
Verandering (1 dag)
6.84%
Verandering (1 jaar)
0.00%
Land
GB
Handel Synairgen plc (SNG)

Categorie

EPS voor Synairgen plc (SNG)
EPS per June 2024 TTM: $-0.04
Volgens de laatste financiële rapporten en de aandelenkoers van Synairgen plc is de huidige EPS van het bedrijf (TTM) $-0.04. Eind 2022 had het bedrijf een EPS van $-0.11, een daling ten opzichte van de EPS van 2021 die $-0.32 bedroeg.
EPS-geschiedenis van Synairgen plc van 2004 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
2026 (TTM) $-0.04 -13.00%
2023 $-0.05 -49.81%
2022 $-0.11 -67.33%
2021 $-0.32 150.97%
2020 $-0.13 176.28%
2019 $-0.05 5.88%
2018 $-0.04 -274.70%
2017 $0.03 -166.75%
2016 $-0.04 4.12%
2015 $-0.04 -273.33%
2014 $0.02 -146.98%
2013 $-0.04 -11.13%
2012 $-0.05 -41.31%
2011 $-0.09 34.96%
2010 $-0.06 -65.03%
2009 $-0.18 -7.49%
2008 $-0.20 44.55%
2007 $-0.14 67.04%
2006 $-0.08 39.93%
2005 $-0.06 112.04%
2004 $-0.03 0.00%
EPS van vergelijkbare bedrijven of concurrenten
Bedrijf EPS EPS-verschil Land
$17.32 -39,916.09%
US
$27.74 -63,870.11%
NL
- -
CH
- -
KR
$13.70 -31,594.48%
BE